Expression of p73 in normal skin and proliferative skin lesions

Pathology International

Volumn 54, Issue 12, 2004, Pages 890-895

  Kamiya, Makoto ^a   Takeuchi, Yuko ^a   Katho, Mari ^a   Yokoo, Hideaki ^a   Sasaki, Atsushi ^a   Nakazato, Yoichi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Differentiation; p53; p73; Skin

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; PROTEIN P73;

ARTICLE; BASAL CELL; BASAL CELL CARCINOMA; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLUMNAR EPITHELIUM; GENE EXPRESSION; HAIR FOLLICLE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MEIBOMIAN GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEBACEOUS GLAND; SEBORRHEIC KERATOSIS; SECRETORY CELL; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SWEAT GLAND; TUMOR CELL;

CARCINOMA, BASAL CELL; CELL PROLIFERATION; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, SEBORRHEIC; KI-67 ANTIGEN; NEOPLASMS, SQUAMOUS CELL; NUCLEAR PROTEINS; SKIN; SKIN DISEASES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 11244320900     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01777.x     Document Type: Article

References (24)

1. Kaghad M, Bonnet H, Yang A et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90: 809-19.
2. Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci 2000; 113: 1661-70.
3. Donehower LA, Harvey M, Slagle BL et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215-21.
4. Kaelin WG Jr. The emerging p53 gene family. J Natl Cancer Inst 1999; 91: 594-8.
5. Yang A, Walker N, Bronson R et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000; 404: 99-103.
6. Kaelin WG Jr. The p53 gene family. Oncogene 1999; 18: 7701-5.
7. Ichimiya S, Nakagawara A, Sakuma Y et al. p73: structure and function. Pathol Int 2000; 50: 589-93.
8. Davis PK, Dowdy SF. p73. Int J Biochem Cell Biol 2001; 33: 935-9.
9. Arrowsmith CH. Structure and function in the p53 family. Cell Death Differ 1999; 6: 1169-73.
10. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708-13.
11. Yang A, Schweitzer R, Sun D et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714-18.
12. Faridoni-Laurens L, Bosq J, Janot F et al. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene 2001; 20: 5302-12.
13. Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 2002; 33: 158-64.
14. Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck. Int J Cancer 2002; 98: 22-8.
15. De Laurenzi V, Rossi A, Terrinoni A et al. p63 and p73 transactivate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Commun 2000; 273: 342-6.
16. Kang MJ, Park BJ, Byun DS et al. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin Cancer Res 2000; 6: 1767-71.
17. Tokuchi Y, Hashimoto T, Kobayashi Y et al. The expression of p73 is increased in lung cancer, independent of p53 gene alteration. Br J Cancer 1999; 80: 1623-9.
18. Zaika AI, Kovalev S, Marchenko ND, Moll UM. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res 1999; 59: 3257-63.
19. Yokomizo A, Mai M, Tindall DJ et al. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene 1999; 18: 1629-33.
20. Cai YC, Yang GY, Nie Y et al. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis 2000; 21: 683-9.
21. Tannapfel A, Wasner M, Krause K et al. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 1999; 91: 1154-8.
22. Chi SG, Chang SG, Lee SJ, Lee CH, Kim JI, Park JH. Elevated and biallelic expression of p73 is associated with-progression of human bladder cancer. Cancer Res 1999; 59: 2791-3.
23. Ito Y, Takeda T, Wakasa K, Tsujimoto M, Sakon M, Matsuura N. Expression of p73 and p63 proteins in pancreatic adenocarcinoma: p73 overexpression is inversely correlated with biological aggressiveness. Int J Mol Med 2001; 8: 67-71.
24. Tannapfel A, Engeland K, Weinans L et al. Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. Br J Cancer 1999; 80: 1069-74.